New York is home to a diverse set of venture capital funds spanning seed specialists, multi-stage platforms, and sector-focused investors. Our New York funds coverage helps founders identify the right NYC investors for their stage, sector, and round size.
Explore New York venture capital funds and investor profiles below.
New York-based Eckuity Capital announced the first close of Fund II on June 26, 2026, extending its commercial-stage life sciences growth strategy across North America and Europe.
New York-based Colbeck Capital Management launched Colbeck Strategic Income with $400M on June 24, 2026, expanding its middle-market private credit platform.
AlleyCorp led a round for Vanna Health, which delivers evidence-based care for people living with serious mental illness, extending the firm’s healthcare vertical.
New York-based Relentless closed its debut fund at over $80 million in 2026, founded by former Index Ventures partner Damir Becirovic with a concentrated seed strategy.
NYC-focused Tribeca Venture Partners backed Bland’s Series C and Gather AI’s Series B, continuing its Series A-led, New York tech thesis.
New York-based Gutter Capital announced the $75M close of Fund III on June 15, 2026, alongside applications for the second cohort of its NYC Elbow Grease accelerator.
